非对比自由呼吸心电门控三维平衡稳态自由进动序列在先天性心脏病及主动脉病变评估中的应用
本研究以对比增强三维bSSFP为参考,评估自由呼吸心电门控非对比三维bSSFP在先天性心脏病及主动脉病变中的图像质量与血管测量准确性,并辅以常规非心电门控二维单次激发bSSFP。29例患者(含11例儿童)结果显示对比增强图像质量评分显著更高,但非对比三维联合二维bSSFP可提供诊断可接受的图像质量及与对比增强三维bSSFP相当的血管测量值。
要点
- 非对比三维bSSFP联合二维单次激发bSSFP在435个血管节段中分别有423和420个被两位读者评为可诊断。
- 非对比与对比增强三维bSSFP的血管直径测量高度一致(r=0.99,偏倚-0.31 mm)。
- 对比增强三维bSSFP整体图像质量评分显著高于非对比三维bSSFP(P<0.0001)。
核心结论
- 尽管对比增强图像整体质量更优,非对比二维单次激发bSSFP联合三维bSSFP全胸图像在儿童和成人先心病及主动脉病变中可提供诊断可接受的图像质量及与自由呼吸对比增强三维bSSFP相当的准确血管测量。
研究设计与样本
- 单中心回顾性分析,作为临床质量改进项目的一部分前瞻性识别接受临床指征对比增强三维bSSFP的患者并额外进行非对比三维bSSFP和二维单次激发bSSFP成像。
诊断标准与关键数值
- 图像质量采用5分Likert量表评分,对比增强三维bSSFP整体评分4.4±0.2(范围4.0-4.9)显著高于非对比三维bSSFP的3.7±0.4(范围3.1-4.7),P<0.0001。
- 儿童亚组中对比增强三维bSSFP评分4.3±0.3(范围4.0-4.9)显著高于非对比三维bSSFP的3.6±0.5(范围3.1-4.4)。
- 非对比与对比增强三维bSSFP血管直径测量r=0.99,偏倚-0.31 mm,95%一致性界限-2.04 mm至1.43 mm。
- 联合非对比三维bSSFP与二维bSSFP,读者1和读者2在435个血管节段中分别将423和420个评为可诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: High-fidelity cardiac magnetic resonance (MR) imaging plays a pivotal role in the surveillance of congenital heart disease (CHD) and aortopathy.
OBJECTIVE: We aimed to evaluate the quality and accuracy of free breathing, ECG-gated noncontrast three-dimensional (3D) balanced steady-state free precession (bSSFP) in cases of CHDs and aortopathies using contrast-enhanced 3D bSSFP as a reference. We also used one of our routinely used non-ECG-gated 2D-single-shot (SSh) bSSFP sequence as an adjunct to noncontrast 3D bSSFP.
MATERIALS AND METHODS: Institutional review board approval was obtained to perform a systematic retrospective analysis of image quality and vascular measurements. Patients with CHD and aortopathy, who were undergoing clinically indicated contrast-enhanced 3D bSSFP, were prospectively identified to also undergo additional noncontrast 3D bSSFP and 2D SSh bSSFP imaging as part of a clinical quality improvement initiative aimed at reducing the use of contrast when feasible. Two readers, blinded to each other's evaluations, graded image quality on a 5-point Likert scale and performed vascular measurements in separate sessions for both 3D bSSFP images. They also reported the visibility of various mediastinal great vessels on 2D SSh bSSFP images. Raw agreement, the weighted kappa statistic, and intra-class correlation coefficients (ICCs) were computed to assess the consistency and agreement between the two readers. Comparative analysis of noncontrast and contrast-enhanced 3D bSSFP imaging was performed in adult and pediatric patients using a two-sided paired t-test and Bland-Altman analysis. A P-value < 0.05 was considered significant for all inference testing.
RESULTS: A total of 29 patients (17 males, median age 20.3 years, interquartile range (IQR) 12.5, age range 7-39 years), including 11 pediatric patients under the age of 18 years (6 males, median age 14.5 years, IQR 4.0, age range 7-17 years), underwent retrospective analysis. The overall image quality score for contrast-enhanced 3D bSSFP was significantly higher (P < 0.0001) than that of noncontrast 3D bSSFP for both all subjects (4.4 ± 0.2, range 4.0-4.9 vs 3.7 ± 0.4, range 3.1-4.7) and only pediatric subjects (4.3 ± 0.3, range 4.0-4.9 vs 3.6 ± 0.5, range 3.1-4.4). By combining noncontrast 3D bSSFP and 2D bSSFP, reader 1 and reader 2 rated 423 and 420 vessels diagnostic, respectively, in a total of 435 vessel segments. All landmarks showed similar mean vessel diameters without significant differences between noncontrast and contrast-enhanced 3D bSSFP MR angiography (r = 0.99, bias -0.31 mm, 95% limits of agreement -2.04 mm to 1.43 mm).
CONCLUSIONS: Although contrast-enhanced images had better overall image quality, an imaging protocol consisting of noncontrast 2D SSh bSSFP and 3D bSSFP whole-chest images provides diagnostically adequate image quality, and accurate vascular measurements, comparable to free-breathing contrast-enhanced 3D bSSFP in both children and adults with CHD and aortopathies.
引用
- Kocaoglu M, Lang SM, Ta H, et al. Noncontrast free-breathing ECG-gated 3D balanced steady-state free precession in congenital heart disease and aortopathy evaluation. Pediatr Radiol. 2024. PMID: 39164501. doi:10.1007/s00247-024-06024-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。